KLK6 (zyme/ protease M/neurosin) is overexpressed in primary breast and ovarian cancers (Anisowicz et al, 1996) and preliminary studies indicate that it may have utility as a serum biomarker for ovarian carcinoma (Diamandis et al, 2000). This evidence concerns the gene KLK6 and ovarian carcinoma.